ERLOTINIB HYDROCHLORIDE
Substance profile for UNII DA87705X9K, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- DA87705X9K
- Preferred term
- ERLOTINIB HYDROCHLORIDE
- Registry number
- 183319-69-9
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C22H23N3O4.ClH
Chemical And Database Identifiers#
- InChIKey
- GTTBEUCJPZQMDZ-UHFFFAOYSA-N
- SMILES
- Cl.COCCOC1=CC2=NC=NC(NC3=CC=CC(=C3)C#C)=C2C=C1OCCOC
- RxCUI
- 477320
- PubChem
- 0
- NCIt
- C2693
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem InChIKey Search | GTTBEUCJPZQMDZ-UHFFFAOYSA-N |  pubchem.ncbi.nlm.nih.gov/#query=GTTBEUCJPZQMDZ-UHFFFAOYSA-N |
| RxNorm | 477320 |  mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=477320 |
| NCI Thesaurus | C2693 |  ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2693 |
| FDA Substance Registration System | DA87705X9K |  precision.fda.gov/uniisearch/srs/unii/DA87705X9K |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ERLOTINIB HYDROCHLORIDE | ACTIVE INGREDIENT | DA87705X9K | These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA. TARCEVA (erlotinib hydrochloride) tablet for oral use Initial U.S. Approval: 2004 | 1 | |
| erlotinib hydrochloride | ACTIVE INGREDIENT | DA87705X9K | TARCEVA (ERLOTINIB HYDROCHLORIDE) TABLET [GENENTECH, INC.] | 12 | |
| ERLOTINIB HYDROCHLORIDE | ACTIVE INGREDIENT | DA87705X9K | TARCEVA (ERLOTINIB HYDROCHLORIDE) TABLET [AVERA MCKENNAN HOSPITAL] | 1 |